Now Trending: Insurers Dropping Weight Loss Drug Coverage, FDA Approves Novel Parkinson’s Drug

Researchers aimed to discover whether pharmacist-led delivery of oral anticoagulation therapy can lead to an increase in stroke risk reduction for patients with actionable atrial fibrillation.

Researchers compared health care and prescription medication affordability during the COVID-19 pandemic to pre-pandemic numbers.

In a session presented at the 2024 Heart in Diabetes Conference, Matthew Weir, MD, discussed the potential benefits of GLP-1s and SGLT2 inhibitors for improved chronic kidney disease and cardiovascular outcomes.

Researchers analyzed groups of men given financial incentives to motivate weight-loss behaviors compared with a non-incentivized control group.

Altuviiio was first granted approval by the FDA in February 2023.

A review found that many guidelines that recommended pharmacogenetic testing were inconsistent between clinical associations.